In the present study we have compared the immunophenotypic characteristics of the CD56 ϩlo and CD56
INTRODUCTION Natural killer (NK) cells are commonly defined as CD3
Ϫ /TCR Ϫ large granular lymphocytes that express CD56 and/or CD16 and mediate non-MHC restricted cytotoxic functions (1) . Two major NK-cell subsets differing on the expression of CD56 on the cell surface have been described so far: CD56 ϩlo and CD56 ϩhi NK cells (2) . CD56
ϩlo NK-cells predominate in blood whereas CD56
ϩhi NK-cells are more frequently detected in various organs and tissues including the uterine placenta decidua (3) (4) (5) , as well as in the lymphatic fluid (5) . Although it was initially suggested that CD56 ϩhi could represent precursors of the most numerous CD56
ϩlo NK-cells (6) , it was recently shown that CD56
ϩhi NK-cells represent a functionally distinct subset of mature NK-cells which are primarily responsible for cytokine production in response to monokines (7) . In spite of this, it still remains unclear whether CD56 ϩlo and CD56 ϩhi NK-cells correspond to different types of NK-cells or alternatively they represent different maturational/activation states of the same NKcell population. Preliminary studies indicated that CD56 ϩlo and CD56 ϩhi NK-cells show different patterns of expression several surface markers (6, 8) , suggesting that a detailed characterization of the molecules expressed on these NK-cell subsets could potentially contribute to clarify the relationship between them; nevertheless, at present information on the immunophenotypic features of both NK-cell subsets is not detailed enough to provide a comprehensive view of their tissue distribution and functional properties.
To gain further insights into the relationship between these subsets of blood NK-cells in the present study we have compared the immunophenotypic characteristics of CD56 ϩhi with those of the predominating CD56
ϩlo NK-cells, as regard to the expression of killer receptors, activation-related markers, cell adhesion molecules and homing receptors; based on the differences observed, we discuss on the functional relevance of each of these groups of molecules in determining NK-cell function and migratory properties.
MATERIALS AND METHODS

Samples
The enumeration of CD56 ϩlo and CD56
ϩhi NK-cells and the immunophenotypic analysis of these NK-cell subsets were performed in fresh EDTA-K3 anti-coagulated blood samples from six healthy adult individuals (blood donors)-three males and three females-aged from 24 to 38 years (median age of 32 years) who gave informed consent to enter in this study.
Immunophenotypic Studies
Immunophenotypic studies were performed using a whole blood stain-lyse-and-then-wash method and a direct immunofluorescence technique. Briefly, 100 l of whole blood containing between 0.5 and 2 ϫ 10 6 nucleated cells was incubated for 15 min at room temperature (RT) in the darkness, with saturating amounts of the appropriate monoclonal antibodies (MoAb). Lysis of red blood cells and fixation of the leukocytes was then performed by adding 2 ml of FACS lysing solution [Becton/Dickinson Biosciences (BD), San Jose, CA) diluted 1/10 (v/v) in distilled water and incubating the cells for another 10 min at RT. Cells were then washed once by centrifuging at 540g and resuspended in 0.5 ml of phosphate-buffered saline (PBS) for acquisition in the flow cytometer.
The following four-color combinations of MoAb directed against T-and NK-associated antigens conjugated with fluorescein isothiocyanate (FITC)/phycoerythrin (PE)/PE-Cyanine 5 (PE-Cy5) and/allophycocyanin (APC) were used: CD2/CD7/CD56/CD3, CD5/CD7/CD56/ CD3, CD57/CD11c/CD56/CD3, CD38/CD11b/ CD56/CD3, CD16/NKB1/CD56/CD3, CD158a/ CD161/CD56/CD3, CD94/CD8/CD56/CD3, CD122/ CD25/CD56/CD3, CD44/CD40L/CD56/CD3, CD11a/HLA-DR/CD56/CD3, CD45RA/CD45RO/ CD56/CD3, and CD62L/CD28/CD56/CD3. The source and specificity of each of the MoAb reagents are shown in Table 1 .
Data acquisition was carried out in a FACSCalibur flow cytometer (BD) equipped with a 15-mW air-cooled 488-nm argon laser and a 625-nm neon diode laser, using the Cell QUEST software program (BD). Information on a minimum of 2 ϫ 10 5 events was acquired for each staining and stored as list mode data. For data analysis the Paint-a-Gate PRO software program (BD) was used. As a first step, NK-cells were selected based on their CD3 Ϫ /CD56 ϩ phenotype and the proportion of CD56 ϩlo and CD56 ϩhi NKcells within the total CD56 ϩ NK-cell compartment calculated. Then, each NK-cell subset was separately analyzed for both its light-scatter-side scatter (SSC) and forward scatter (FSC)-characteristics and expression of the surface antigens recognized by the MoAb referred above. For each antigenic determinant, the following characteristics were recorded: (i) percentage of positive cells, evaluated as the percentage of cells stained above the negative control value; (ii) intensity of expression, evaluated by the mean fluorescence intensity (MFI), expressed in arbitrary relative linear units of fluorescence scaled from 0 to 10,000; (iii) pattern of antigen expression-homogeneous versus heterogeneous-evaluated by the coefficient of variation (CV). In addition, the relative intensity of expression of each antigen on CD56 
NK-cells compared to CD56
ϩlo NK-cells was evaluated as the ratio between the MFI values for these NK-cell subsets in each individual sample.
Statistical Analysis
For all variables under study, median, mean, standard deviation, minimum and maximum were calculated. To establish the statistical significance of the immunophenotypic differences observed between CD56
ϩlo and CD56 ϩhi NK-cells, the Mann-Whitney U and the 2 tests were used, for continuous and dichotomic variables (SPSS 9.0, SPSS, Chicago, IL). P values less than 0.05 were considered to be associated with statistically significant differences.
RESULTS
CD56
ϩ NK-cells accounted for a mean of 17 Ϯ 8% of the blood lymphocyte compartment in the blood from the 6 normal individuals included in this study, the mean absolute NK-cell count being of 264 Ϯ 183 ϫ 10 6 /L. From the NK-cells, the majority showed dim CD56 expression (CD56 ϩlo ) (mean of 93 Ϯ 7%, ranging from 80 to 99%) while a minor fraction displayed a high reactivity for CD56 (CD56 ϩhi ) (7 Ϯ 7%, ranging from 1 to 20%). These values did not differ significantly from those found in a group of 70 healthy adult individuals used for determination of normal reference values in our lab (93 Ϯ 6% versus 7 Ϯ 6%).
Apart from their differential expression of CD56 these NK-cell subsets displayed distinct light-scatter (FSC and SSC) characteristics. Accordingly, CD56
ϩhi NK-cells showed higher FSC (P ϭ 0.041) and SSC (P ϭ 0.026) values than those observed for CD56
ϩlo NK-cells, with identical FSC and SSC mean ratios (1.1 Ϯ 0.1).
From the phenotypic point of view, CD56
ϩhi NK-cells expressed CD56 at levels that were 6.7-Ϯ 1.5-fold higher than those observed for CD56 ϩlo NK-cells (P ϭ 0.002) ( Fig. 1 ), which in turn exceeded those of CD56 ϩ T-cells by 3.3-Ϯ 1.5-fold. Interestingly, CD56 expression was extremely homogeneous on CD56 ϩhi compared to the CD56
ϩlo NK-cells (P ϭ 0.002). Besides the differential expression observed for CD56, the two NK-cell populations under study also differed in the percentage of cells that stained positively (Table 2 ) and/or on the intensity and pattern of expression (Table 3 and Fig. 1 ) of a large number of other antigens. Such phenotypic differences are illustrated in Fig. 2 and described below in more detail.
T-Cell-Associated Markers
None of the two blood NK-cell subsets showed surface expression of CD3. By contrast, both NKcell subsets expressed the CD2 and CD7 antigens, although in both cases a CD2
Ϫ NK-cell population was identified which represented a mean of 23 Ϯ 11 and 6 Ϯ 3% of CD56 ϩlo and CD56 ϩhi NK-cell subsets, respectively (P ϭ 0.004). Upon comparing the reactivity for both antigens in the CD56 ϩhi and CD56
ϩlo NK-cell subsets it was observed that the former expressed CD2 and CD7 at higher intensities than those observed on CD56 ϩlo cells (ratio of 2.6 Ϯ 0.6 and 2.9 Ϯ 1.2, respectively; P ϭ 0.002 in both cases). In addition, both CD2 and CD7 were more heterogeneously expressed on CD56 ϩlow than on CD56
ϩhi NK-cells (P ϭ 0.004 and 0.041, respectively). A variable proportion of CD56
ϩlo NKcells showed dim CD5 expression (5 Ϯ 7%, ranging from 0 to 18%), a CD56 ϩlo /CD5
ϩlo NK-cell population being clearly identified in 3 out of 6 cases, where they represent 2, 9, and 18% of total CD56 ϩlo NK-cells; in these cases, CD5 expression was homogeneous, and present at levels 9.6-Ϯ 1.2-fold lower than those observed for normal blood T-cells. In contrast, CD56
ϩhi NK-cells were consistently negative for CD5 (P ϭ 0.001).
The mean fraction of CD8 ϩ cells within the CD56 ϩlo (55 Ϯ 16%) and the CD56 ϩhi (54 Ϯ 13%) NK-cell subsets were similar, CD8 expression being rather heterogeneous in both cases.
Adhesion Molecules and Homing Receptors
Virtually all NK-cells constitutively expressed homogeneously high levels of CD11a when compared to other circulating lymphocytes, its intensity of expression being significantly lower on CD56
ϩhi NK-cells compared to the predominating CD56
ϩlo NK-cell subset (ratio of 1.4 Ϯ 0.2; P ϭ 0.002). In contrast, CD11b was heterogeneously expressed on both cell subsets at similar levels (P Ͼ 0.05) whereas CD11c expression was significantly higher on the latter NK-cell subset (ratio of 1.6-Ϯ 0.3-fold; P ϭ 0.041). Additionally, most CD56
ϩhi NK-cells were CD11c ϩ (92 Ϯ 6%) whereas its expression on CD56 ϩlo NK cells was more variable, with a mean fraction of 72 Ϯ 24% CD11c ϩ cells (P ϭ 0.065). Expression of CD11c was relatively heterogeneous on both NK-cell subsets, although lower coefficients of variation were found on CD56 ϩhi than on CD56
ϩlo NK-cells (P ϭ 0.009). In contrast, CD57 was expressed in large fraction of CD56 ϩlo NK whereas CD56 ϩhi were virtually negative for CD57 (mean fraction of CD57 ϩ cells of 66 Ϯ 14 and 1 Ϯ 1%, respectively; P ϭ 0.002). All NK-cells were CD44 ϩ , CD44 expression being significantly higher (ratio of 4.1 Ϯ 1.1; P ϭ 0.002) and more homogeneous (P ϭ 0.032) on CD56 ϩhi compared to CD56 ϩlo NKcells. In addition, nearly all CD56
ϩlo NK-cells expressed CD62L whereas this molecule was negative or dimly positive in only a minor fraction of CD56 ϩlo NK-cells (100 Ϯ 0% versus 14 Ϯ 7%; P ϭ 0.002).
Killer Receptors
In contrast to the CD56 ϩlo NK-cell compartment, in which the majority of cells (98 Ϯ 16%) homogeneously expressed CD16, CD56
ϩhi NKcells either lacked CD16 or showed CD16 expression in a relatively small fraction of cells (mean of 28 Ϯ 16%; P ϭ 0.009) at an intensity 5.5-Ϯ 2.3-fold lower than that observed for the CD56 ϩlo NK-cell population (P ϭ 0.009).
The expression of the immunoglobulin-like NKB1 and CD158a killer receptors on CD56 ϩlo NK-cells was highly variable (mean percentage of positive cells of 16 Ϯ 16 and 18 Ϯ 8%, ranging from 0 to 47% and from 10 to 25%, respectively) whereas both were constantly negative on CD56
ϩhi NK-cells (P ϭ 0.026 and 0.037, respectively).
In that concerning lectin-like killer receptors, virtually all CD56
ϩhi NK-cells expressed CD94 whereas only around half (59 Ϯ 11%) of CD56 ϩlo NK-cells showed dim CD94 expression, the intensity of expression for this molecule being 2.6-Ϯ 0.3-fold higher (P ϭ 0.007) and more homogeneous (P Ͻ 0.001) on CD56 ϩhi compared to CD56
ϩlo NK-cells. In contrast, reactivity for CD161 was relatively heterogeneous in both NKcell subsets, although the intensity of CD161 expression was higher on CD56
ϩhi NK-cells (P ϭ 0.004).
Costimulatory Molecules, Cytokine Receptors, and Activation-Related Markers
All NK-cells constitutively expressed high levels of CD45RA. The intensity of CD45RA expression was 1.7-Ϯ 0.7-fold higher (P ϭ 0.016) and more homogeneous (P ϭ 0.026) on CD56 ϩlo than on CD56 ϩhi NK cells. Although the vast majority of NK-cells were CD45RO
ϩ NK-cells were detected within both cell subsets, its percentage being higher among CD56
ϩhi NK-cells (12 Ϯ 5% versus 4 Ϯ 4%; P ϭ 0.026). In both cases CD45RO ϩ /CD45RA
ϩ NK-cells expressed lower levels of CD45RA than CD45RA ϩ CD45RO
Ϫ NK-cells, expression of CD45RO being constantly dim and heterogeneous. CD122 was constitutively expressed on virtually all NK-cells, its intensity of expression being 2.3-Ϯ 0.6-fold higher on CD56
ϩhi NK-cells (P ϭ 0.002). Few CD56
ϩlo NK-cells coexpressed CD25 (1 Ϯ 1%) whereas a relatively high proportion of CD56
ϩhi NK-cells was CD25
ϩlo (22 Ϯ 9%) (P ϭ 0.002). The mean proportion of HLA-DR ϩ cells was also higher among CD56
ϩhi NK-cells (83 Ϯ 8% versus 23 Ϯ 13%; P ϭ 0.002). Both NK-cell populations displayed similar patterns of CD38 expression (P Ͼ 0.05).
The CD28 costimulatory molecule was constantly absent in the two NK-cell subsets here analyzed in all blood samples studied, as did the CD40 ligand (CD154).
DISCUSSION
In the present study we confirm and extend previous observations as regards the presence in the blood from normal individuals of two distinct populations of NK-cells defined by differential levels of CD56 expression. While the CD56 ϩlo subset constantly represent the major fraction of NK-cells, the CD56
ϩhi only accounts for a minor proportion of CD56 ϩ NK-cells present in blood. Interestingly, these NK-cell subsets showed distinct light scatter properties, higher FSC and SSC values being found for the CD56 ϩhi NK-cells, supporting the existence of differences between these NK-cell subsets as regards both size and the cell internal complexity/granularity. Additionally, both cell subsets displayed distinct immunophenotypic patterns for a great part of the surface proteins analyzed, which may be related to distinct functional and migratory properties (9 -15) . As an example, receptors that regulate adhesion to vascular endothelium and extracellular matrix might contribute to a differential representation of these NK-cell subsets in blood as well as in tissues; in a similar way, differences on the expression of killer receptors, NK-cell costimulatory molecules and cytokine receptors may have a determinant role on the differential capacity of these NK-cell subsets to proliferate and being 
FIG. 2. Representative dot plots illustrating the distinct immunophenotypic patterns observed for the CD56
ϩlo (red dots) and CD56 ϩhi (black dots) blood NK-cells subsets from an adult healthy individual. Events painted in gray correspond to blood T-cells present in the sample. Lima 
In that concerning to adhesion molecules that may favor homing of NK-cells to different tissues, it should be noted that CD62L-the L-selectin adhesion molecule that mediates interaction of leukocytes with peripheral lymph node high endothelial venules (HEV) (16, 17) -and CD44 -a molecule that mediates adhesion by acting as the hyaluronate receptor and promotes NK-cell homing by binding to mucosal HEV (18, 19) -were preferentially expressed in CD56 ϩhi compared CD56
ϩlo NK-cells in accordance to previous observations (8, 20) . These findings might at least in part explain why CD56 ϩhi more efficiently bind to HEV than CD56
ϩlo NK-cells (20) and could contribute to a preferential homing of CD56
ϩhi NK-cells into different human tissues where they are found at higher frequencies (3) (4) (5) .
Other adhesion molecules, such as the ␤1-integrins (21) have also been shown to be involved in the adhesion to vascular endothelium and transmigration across endothelial cells by means of different interactions, including those between CD11a and CD11b and their ligands (CD54, CD102, and fibrinogen) (22) (23) (24) (25) (26) (27) (28) (29) (30) . In the present study we show, in accordance to previous studies (8) , that CD11a is expressed on NK-cells at higher levels than those observed in other blood cells, a characteristic that probably contributes to the greater migratory properties of NK-cells compared to other circulating lymphocyte subsets. Nevertheless, differences on the expression of CD11a cannot explain the preferential localization of CD56 ϩhi compared to CD56 ϩlo NK-cells in tissues, as the intensity expression of CD11a is slightly lower in the former NK-cell subset. For the same reasons, differences on the expression of CD11b can neither account for the higher migratory properties of CD56
ϩhi NK-cells. The meaning of the finding that CD11c is preferentially expressed on CD56
ϩhi NK-cells is not known. However, in a similar way to that occurring for CD11b (31, 32) , both C3bi (33, 34) , fibrinogen (35) and CD54 (36) have been proposed as ligands for CD11c and this molecule has been claimed to be involved in adhesion to the endothelium and to the extracellular matrix (36), as well as to play a role in conjugate formation between NK-cells and target cells (37) . The significance of the exclusive expression of CD57-an oligosaccharide with sulfated glucoronic acid residues that is expressed on T-cells during advanced phases of immune responses and that presumably also mediates cell adhesion (38)-on CD56
ϩlo NK-cells is neither clear. Besides determining adhesion properties and migratory capabilities, adhesion molecules may also be crucial for conjugate formation between NK-cells and target cells, a process that depends on the homophilic binding mediated by CD56 (39, 40) and on other pairs of receptors such as CD11a/CD54 (41, 42) , CD2/CD58 (43, 44) , and CD8/MHC-class I antigens (45, 46) . Accordingly, the higher expression of CD56 and CD2 found on CD56
ϩhi NK-cells may favor a closer interaction between these NK-cells and their targets.
Cytotoxicity depends on a delicate balance between different groups of receptors that either activate or inhibit the NK-cell killer functions (47) (48) (49) connecting to adapter molecules and turning on/off different signal-transducing pathways (50 -53) .
CD16 -the ␣-chain of the low-affinity receptor for the Fc portion of IgG (Fc␥RIII)-activates cytotoxicity on NK-cells through its binding to immune-complexed IgG and plays a determinant role in NK-cell proliferation and both antibodydependent and antibody-independent cell cytotoxicity (54 -59) . Absence or low intensity of expression of CD16 may explain at least to a certain extent why both blood and decidual CD56 ϩhi NK-cells are less efficient in mediating non-MHC-restricted cytotoxicity than the CD56 ϩlo NK-cells (2, 60, 61) . Antibody-independent NKcell cytotoxic activity is usually related to signals mediated by multiple immunoglobulin-like (CD158, NKB1; NKp44; NKp46) and lectin-like (CD94, CD161) receptors which may act through an MHC class I dependent (CD94, CD158, and NKB1) or independent (CD161) pathway (62) (63) (64) (65) (66) . Positive stimulation may be initiated through the activation forms of some of the MHC-dependent receptors, such as CD158 and CD94, and other non-MHC restricted triggering molecules, such as CD161, whereas suppresser signals derive from inhibitory forms of the MHC-dependent receptors mentioned above. As a consequence of these regulatory mechanisms, differences on the expression of killer receptors may determine different MHC-dependent activator/suppressive requirements for CD56 ϩlo and CD56 ϩhi NK-cell subsets. For instance, the fact that CD56
ϩhi NKcells do not express CD158a and NKB1 whereas they strongly express CD94, may determine specificity for non-classical HLA-E molecules, whereas the opposite pattern of expression of CD158a and NKB1 with low reactivity for CD94 usually observed on CD56
ϩlo NK-cells would suggest a preferential recognition of classical MHC class I A, B, and C molecules by this cell subset (67) (68) (69) .
Higher levels of other molecules that exhibit NK-cell costimulatory functions on CD56
ϩhi NKcells such as CD2 (70 -72) , CD7 (73, 74) , CD38 (75, 76) , and CD44 (77, 78) , may also be related to a higher ability of NK56
ϩhi NK-cells to respond to different stimuli. By contrast, and in accordance to previous reports, we were not able to detect surface expression of neither the CD28 (79) nor the CD40L (CD154) (80) costimulatory molecules on NK-cells.
Interestingly, CD56 ϩhi NK-cells exhibited a phenotype suggestive of cell activation, as reflected by a higher fraction of HLA-DR ϩ and CD25 ϩ cells (81, 82) . The lower intensity of expression of CD45RA and the highest proportion of CD45RA ϩ /CD45RO ϩ cells among CD56 ϩhi NK-cells may also be a signal of NK-cell activation, since previous studies have shown that activated NK-cells transiently acquire CD45RO, a phenomena that is accompanied by a decrease on CD45RA expression (83) . NK-cells proliferate and display enhanced cytotoxic activity in response to various cytokines and growth factors, including IL-2 (84 -89). Consequently, differences on the expression of cytokine receptors would probably contribute to the different ability of these NK-cell subsets to be activated and to proliferate in response to specific cytokines. The fact that CD122-IL-2R ␤-chain-is constitutively expressed with a higher intensity on CD56
ϩhi NK-cells at the same time that a higher fraction of these cells express CD25-IL-2R ␣-chain-could probably explain why CD56
ϩhi NK-cells display a preferential response to low doses of IL-2 with increased cytolytic activity and proliferation compared to the CD56 ϩlo NK-cell subset (90 -94) . In summary, our results show that CD56 ϩhi and CD56
ϩlo NK-cells display distinct phenotypic characteristics suggesting that the former cells may correspond to a previously activated NK-cell subset with a different pattern of recognition of MHC molecules and different requirements to undergo proliferation and activation of its cytotoxic functions at the same time that they would explain its higher ability to migrate into different human tissues.
